Literature DB >> 19040601

Analysis of T cell receptor Vbeta diversity in peripheral CD4 and CD8 T lymphocytes in patients with autoimmune thyroid diseases.

M Okajima1, T Wada, M Nishida, T Yokoyama, Y Nakayama, Y Hashida, F Shibata, Y Tone, A Ishizaki, M Shimizu, T Saito, K Ohta, T Toma, A Yachie.   

Abstract

Autoimmune thyroid diseases are characterized by intrathyroidal infiltration of CD4(+) and CD8(+) T lymphocytes reactive to self-thyroid antigens. Early studies analysing T cell receptor (TCR) Valpha gene usage have shown oligoclonal expansion of intrathyroidal T lymphocytes but not peripheral blood T cells. However, TCR Vbeta diversity of the isolated CD4(+) and CD8(+) T cell compartments in the peripheral blood has not been characterized fully in these patients. We performed complementarity-determining region 3 (CDR3) spectratyping as well as flow cytometric analysis for the TCR Vbeta repertoire in peripheral CD4(+) and CD8(+) T cells from 13 patients with Graves' disease and 17 patients with Hashimoto's thyroiditis. Polyclonal TCR Vbeta repertoire was demonstrated by flow cytometry in both diseases. In contrast, CDR3 spectratyping showed significantly higher skewing of TCR Vbeta in peripheral CD8(+) T cells but not CD4(+) T cells among patients with Hashimoto's thyroiditis compared with healthy adults. We found trends towards a more skewed CDR3 size distribution in those patients having disease longer than 5 years and requiring thyroid hormone replacement. Patients with Graves' disease exhibited no skewing both in CD4(+) and CD8(+) T cells. These findings indicate that clonal expansion of CD8(+) T cells in Hashimoto's thyroiditis can be detected in peripheral blood and may support the role of CD8(+) T cells in cell-mediated autoimmune attacks on the thyroid gland in Hashimoto's thyroiditis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19040601      PMCID: PMC2675246          DOI: 10.1111/j.1365-2249.2008.03842.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Somatic mosaicism in Wiskott--Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism.

Authors:  T Wada; S H Schurman; M Otsu; E K Garabedian; H D Ochs; D L Nelson; F Candotti
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  CDR3 spectratyping analysis of the TCR repertoire in myasthenia gravis.

Authors:  Yoh Matsumoto; Hidenori Matsuo; Hiroshi Sakuma; Il-Kwon Park; Yukiko Tsukada; Kuniko Kohyama; Takayuki Kondo; Satoshi Kotorii; Noritoshi Shibuya
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

3.  Clonotypic analysis of T cell reconstitution after haematopoietic stem cell transplantation (HSCT) in patients with severe combined immunodeficiency.

Authors:  H Okamoto; C Arii; F Shibata; T Toma; T Wada; M Inoue; Y Tone; Y Kasahara; S Koizumi; Y Kamachi; Y Ishida; J Inagaki; M Kato; T Morio; A Yachie
Journal:  Clin Exp Immunol       Date:  2007-03-21       Impact factor: 4.330

4.  Analysis of T-cell repertoire diversity in Wiskott-Aldrich syndrome.

Authors:  Taizo Wada; Shepherd H Schurman; Elizabeth K Garabedian; Akihiro Yachie; Fabio Candotti
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

Review 5.  Role of chemokines in endocrine autoimmune diseases.

Authors:  Mario Rotondi; Luca Chiovato; Sergio Romagnani; Mario Serio; Paola Romagnani
Journal:  Endocr Rev       Date:  2007-05-02       Impact factor: 19.871

6.  Oligoclonal expansion of circulating and tissue-infiltrating CD8+ T cells with killer/effector phenotypes in juvenile dermatomyositis syndrome.

Authors:  K Mizuno; A Yachie; S Nagaoki; H Wada; K Okada; M Kawachi; T Toma; A Konno; K Ohta; Y Kasahara; S Koizumi
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

7.  Skin infiltration of CD56(bright) CD16(-) natural killer cells in a case of X-SCID with Omenn syndrome-like manifestations.

Authors:  Fumie Shibata; Tomoko Toma; Taizo Wada; Masayuki Inoue; Yumi Tone; Kazuhide Ohta; Yoshihito Kasahara; Fumie Sano; Mitsuaki Kimura; Mitsuru Ikeno; Shoichi Koizumi; Akihiro Yachie
Journal:  Eur J Haematol       Date:  2007-07       Impact factor: 2.997

8.  Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma.

Authors:  Nikhil Yawalkar; Katalin Ferenczi; David A Jones; Keiichi Yamanaka; Ki-Young Suh; Sarah Sadat; Thomas S Kupper
Journal:  Blood       Date:  2003-06-26       Impact factor: 22.113

9.  Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto's thyroiditis.

Authors:  Gherardo Mazziotti; Francesca Sorvillo; Caterina Naclerio; Angelo Farzati; Michele Cioffi; Rossella Perna; Gabriele Valentini; Bartolomeo Farzati; Giovanni Amato; Carlo Carella
Journal:  Eur J Endocrinol       Date:  2003-04       Impact factor: 6.664

Review 10.  The many important facets of T-cell repertoire diversity.

Authors:  Janko Nikolich-Zugich; Mark K Slifka; Ilhem Messaoudi
Journal:  Nat Rev Immunol       Date:  2004-02       Impact factor: 53.106

View more
  17 in total

1.  Profiling the repertoire of T-cell receptor beta-chain variable genes in peripheral blood lymphocytes from subjects who have recovered from acute hepatitis B virus infection.

Authors:  Jiezuan Yang; Jiajia Chen; Jianqin He; Yirui Xie; Yixing Zhu; Hongcui Cao; Lanjuan Li
Journal:  Cell Mol Immunol       Date:  2014-07       Impact factor: 11.530

Review 2.  Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells.

Authors:  Noah A Kaitz; Cindy L Zuleger; Peng Yu; Michael A Newton; Richard J Albertini; Mark R Albertini
Journal:  Mutat Res Rev Mutat Res       Date:  2022-03-11       Impact factor: 7.015

3.  HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers.

Authors:  Mary L Disis; Yushe Dang; Andrew L Coveler; Edmond Marzbani; Zhong C Kou; Jennifer S Childs; Patricia Fintak; Doreen M Higgins; Jessica Reichow; James Waisman; Lupe G Salazar
Journal:  Cancer Immunol Immunother       Date:  2013-10-26       Impact factor: 6.968

4.  The Effect of Inhibitory Signals on the Priming of Drug Hapten-Specific T Cells That Express Distinct Vβ Receptors.

Authors:  Andrew Gibson; Lee Faulkner; Maike Lichtenfels; Monday Ogese; Zaid Al-Attar; Ana Alfirevic; Philipp R Esser; Stefan F Martin; Munir Pirmohamed; B Kevin Park; Dean J Naisbitt
Journal:  J Immunol       Date:  2017-07-07       Impact factor: 5.422

5.  Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF).

Authors:  Jiezuan Yang; Ping Yi; Li Wei; Zherong Xu; Yunbo Chen; Lingling Tang; Lanjuan Li
Journal:  J Transl Med       Date:  2012-09-15       Impact factor: 5.531

6.  Urothelial antigen-specific CD4+ T cells function as direct effector cells and induce bladder autoimmune inflammation independent of CD8+ T cells.

Authors:  W Liu; X Chen; D P Evanoff; Y Luo
Journal:  Mucosal Immunol       Date:  2011-01-26       Impact factor: 7.313

7.  Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B.

Authors:  Jiezuan Yang; Jianqin He; Haifeng Lu; Li Wei; Sujun Li; Baohong Wang; Hongyan Diao; Lanjuan Li
Journal:  J Transl Med       Date:  2011-12-08       Impact factor: 5.531

8.  Possible involvement of regulatory T cell abnormalities and variational usage of TCR repertoire in children with autoimmune neutropenia.

Authors:  S Goda; S Hayakawa; S Karakawa; S Okada; H Kawaguchi; M Kobayashi
Journal:  Clin Exp Immunol       Date:  2020-12-27       Impact factor: 5.732

9.  Monitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology.

Authors:  J Lori Blanchfield; Shayla K Shorter; Brian D Evavold
Journal:  Front Immunol       Date:  2013-07-03       Impact factor: 7.561

10.  Flow cytometric analysis of the CD4+ TCR Vβ repertoire in the peripheral blood of children with type 1 diabetes mellitus, systemic lupus erythematosus and age-matched healthy controls.

Authors:  Flora Tzifi; Maria Kanariou; Marianna Tzanoudaki; Constantinos Mihas; Evangelia Paschali; George Chrousos; Christina Kanaka-Gantenbein
Journal:  BMC Immunol       Date:  2013-08-03       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.